These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 24041887)

  • 21. Increased 3-gram cefazolin dosing for cesarean delivery prophylaxis in obese women.
    Swank ML; Wing DA; Nicolau DP; McNulty JA
    Am J Obstet Gynecol; 2015 Sep; 213(3):415.e1-8. PubMed ID: 26003059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Penetration of antibiotics into the surgical wound in a canine model.
    Rosin E; Ebert S; Uphoff TS; Evans MH; Schultz-Darken NJ
    Antimicrob Agents Chemother; 1989 May; 33(5):700-4. PubMed ID: 2751283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A pilot and feasibility study of the plasma and tissue pharmacokinetics of cefazolin in an immature porcine model of pediatric cardiac surgery.
    Kilbaugh TJ; Himebauch AS; Zaoutis T; Jobes D; Greeley WJ; Nicolson SC; Zuppa AF
    Paediatr Anaesth; 2015 Nov; 25(11):1111-9. PubMed ID: 26372607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacodynamics of tigecycline against phenotypically diverse Staphylococcus aureus isolates in a murine thigh model.
    Crandon JL; Banevicius MA; Nicolau DP
    Antimicrob Agents Chemother; 2009 Mar; 53(3):1165-9. PubMed ID: 19114676
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cefazolin bolus and continuous administration for elective cardiac surgery: improved pharmacokinetic and pharmacodynamic parameters.
    Adembri C; Ristori R; Chelazzi C; Arrigucci S; Cassetta MI; De Gaudio AR; Novelli A
    J Thorac Cardiovasc Surg; 2010 Aug; 140(2):471-5. PubMed ID: 20570290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma and target-site subcutaneous tissue population pharmacokinetics and dosing simulations of cefazolin in post-trauma critically ill patients.
    Roberts JA; Udy AA; Jarrett P; Wallis SC; Hope WW; Sharma R; Kirkpatrick CM; Kruger PS; Roberts MS; Lipman J
    J Antimicrob Chemother; 2015 May; 70(5):1495-502. PubMed ID: 25608584
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics and Tissue Penetration of Ceftolozane-Tazobactam in Diabetic Patients with Lower Limb Infections and Healthy Adult Volunteers.
    Monogue ML; Stainton SM; Baummer-Carr A; Shepard AK; Nugent JF; Kuti JL; Nicolau DP
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28893779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Continuous cefazolin infusion to treat bone and joint infections: clinical efficacy, feasibility, safety, and serum and bone concentrations.
    Zeller V; Durand F; Kitzis MD; Lhotellier L; Ziza JM; Mamoudy P; Desplaces N
    Antimicrob Agents Chemother; 2009 Mar; 53(3):883-7. PubMed ID: 19075069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Population pharmacokinetics and pharmacodynamic target attainment analysis of cefazolin using total and unbound serum concentration in patients with prostatectomy or nephrectomy.
    Komatsu T; Kawai Y; Takayama Y; Akamada Y; Kusume E; Ikeda M; Tsumura H; Ishii D; Iwamura M; Okamoto H; Hanaki H; Otori K
    Antimicrob Agents Chemother; 2024 Jul; 68(7):e0026724. PubMed ID: 38771029
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics and tissue concentrations of cefazolin in pediatric patients undergoing gastrointestinal surgery.
    Nahata MC; Durrell DE; Ginn-Pease ME; King DR
    Eur J Drug Metab Pharmacokinet; 1991; 16(1):49-52. PubMed ID: 1936061
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cefazolin tissue concentrations with a prophylactic dose administered before sleeve gastrectomy in obese patients: a single centre study in 116 patients.
    Cinotti R; Dumont R; Ronchi L; Roquilly A; Atthar V; Grégoire M; Planche L; Letessier E; Dailly E; Asehnoune K
    Br J Anaesth; 2018 Jun; 120(6):1202-1208. PubMed ID: 29793587
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of cefazolin prophylaxis in obese gravidae at time of cesarean delivery.
    Young OM; Shaik IH; Twedt R; Binstock A; Althouse AD; Venkataramanan R; Simhan HN; Wiesenfeld HC; Caritis SN
    Am J Obstet Gynecol; 2015 Oct; 213(4):541.e1-7. PubMed ID: 26103528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Once-daily cefazolin and probenecid for skin and soft tissue infections.
    Cox VC; Zed PJ
    Ann Pharmacother; 2004 Mar; 38(3):458-63. PubMed ID: 14970368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetic characteristics and microbiologic appropriateness of cefazolin for perioperative antibiotic prophylaxis in elective cardiac surgery.
    Lanckohr C; Horn D; Voeller S; Hempel G; Fobker M; Welp H; Koeck R; Ellger B
    J Thorac Cardiovasc Surg; 2016 Aug; 152(2):603-10. PubMed ID: 27209020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glycopeptide bone penetration in patients with septic pseudoarthrosis of the tibia.
    Garazzino S; Aprato A; Baietto L; D'Avolio A; Maiello A; De Rosa FG; Aloj D; Siccardi M; Biasibetti A; Massè A; Di Perri G
    Clin Pharmacokinet; 2008; 47(12):793-805. PubMed ID: 19026035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In Vivo Pharmacodynamic Target Investigation of Two Bacterial Topoisomerase Inhibitors, ACT-387042 and ACT-292706, in the Neutropenic Murine Thigh Model against Streptococcus pneumoniae and Staphylococcus aureus.
    Lepak AJ; Seiler P; Surivet JP; Ritz D; Kohl C; Andes DR
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3626-32. PubMed ID: 27044547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determination of appropriate weight-based cutoffs for empiric cefazolin dosing using data from a phase 1 pharmacokinetics and safety study of cefazolin administered for surgical prophylaxis in pediatric patients aged 10 to 12 years.
    Schmitz ML; Blumer JL; Cetnarowski W; Rubino CM
    Antimicrob Agents Chemother; 2015 Jul; 59(7):4173-80. PubMed ID: 25941220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Desired vancomycin trough serum concentration for treating invasive methicillin-resistant Staphylococcal infections.
    Frymoyer A; Guglielmo BJ; Hersh AL
    Pediatr Infect Dis J; 2013 Oct; 32(10):1077-9. PubMed ID: 23652479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo microdialysis to measure antibiotic penetration into soft tissue during cardiac surgery.
    Hutschala D; Skhirtladze K; Kinstner C; Mayer-Helm B; Müller M; Wolner E; Tschernko EM
    Ann Thorac Surg; 2007 Nov; 84(5):1605-10. PubMed ID: 17954069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo microdialysis study of the penetration of daptomycin into soft tissues in diabetic versus healthy volunteers.
    Kim A; Suecof LA; Sutherland CA; Gao L; Kuti JL; Nicolau DP
    Antimicrob Agents Chemother; 2008 Nov; 52(11):3941-6. PubMed ID: 18779352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.